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 Aggregation transits from 2nd to 1st order as intermediate depletes during refolding.
 Better prediction in batch and pulse refolding using proposed transition model.
 Native model protein (sGFPmut3.1) does not aggregate with intermediates.
 Potential engineering tool to optimize in vitro refolding in bioprocess settings.
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a b s t r a c t
Pulse refolding is a strategy to overcome concentration dependent aggregation, assuming that
aggregation is signiﬁcantly suppressed under diluted conditions. When a typical 2nd or higher order
aggregation kinetics is assumed, kinetics over predicted yields at low refolding concentrations. Using
GFP as our model protein, we found a transition in aggregation kinetics from 2nd to 1st order when
intermediates deplete from 100 to 60 mg/ml. Taking this transition into account, the model can better
predict refolding yields in batch and pulse refolding strategies. This model is suited for the design of
refolding processes since this deviation from 2nd or higher order aggregation was also previously
observed in other proteins.
& 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Pulse refolding is a strategy to overcome aggregation by feeding
denatured proteins in discrete amounts over speciﬁc time intervals
into refolding buffer. Previous work showed improved yields when
performed in both batch and continuous reactors (Katoh and Katoh,
2000; Linke et al., 2014; Pan et al., 2014; Schlegl et al., 2005; Winter
et al., 2002). Other strategies for improving yield and productivity
include buffer optimization (Berg et al., 2012; Mannall et al., 2009;
Ordidge et al., 2012), better mixing (Mannall et al., 2006), on-column
refolding (Li et al., 2004; Schmoeger et al., 2009) and annular
chromatography (Uretschlager and Jungbauer, 2002)
However, to accurately quantify process performance and opti-
mize process of these refolding strategies, a robust kinetic model
that satisﬁes different reactor formats is beneﬁcial (Buswell and
Middelberg, 2003). Moreover, a correct biomolecular reaction
scheme would help facilitate product quality and acceptable varia-
bility of process parameters by serving as a mechanistic model
support tool in Process Analytical Technology (PAT) (Glassey et al.,
2011) as part of the Quality by Design (QbD) concept (Rathore and
Winkle, 2009) in biomanufacturing.
The key criteria in developing rigorous kinetic models of
biologics require knowledge of the simplest correct kinetic
scheme (Buswell and Middelberg, 2003). For example, a kinetic
scheme for lysozyme refolding and aggregation that involved a
sequential polymerization with the folding intermediates and the
native protein (Buswell and Middelberg, 2003) as well as the
competition between aggregation and self-assembly during virus-
like particle processing (Ding et al., 2010).
Similarly, our objective is to characterize and establish a simple
but process-suited model to predict in vitro refolding yields. Current
models proposing a ﬁxed 2nd or higher aggregation order (Hevehan
and De Bernardez Clark, 1997; Kiefhaber et al., 1991) overestimate
yields at low protein concentrations. This was seen for lysozyme
(Buswell and Middelberg, 2003), autoprotease EDDIE-pep6His (Kaar
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et al., 2009) and insulin growth factors (Milner et al., 1995) where
yields did not reach 100% at low refolding concentrations. This
suggests a deviation from 2nd and higher order aggregation at dilute
conditions.
Consequently, using the mutant sGFPmut3.1 (Franke et al., 2007)
recovered from inclusion bodies (IBs) lacking the mature chromo-
phore as our model protein (Reid and Flynn, 1997), we proposed a
refolding model where aggregation transits from 2nd to 1st order
aggregation as intermediates deplete below a critical concentration.
Importantly, this study accounts for the protein concentration,
denaturant and reducing agent concentrations during refolding.
The effect on refolding due to the presence of native sGFPmut3.1
was also tested. To test the predictability of our model on other
refolding strategies, pulse refolding experiments were also per-
formed at different refolding conditions.
2. Materials and methods
2.1. Expression and inclusion body recovery
Unless stated otherwise, all chemicals were obtained from
Sigma Aldrich (St. Louis, MO, USA). Recombinant protein
sGFPmut3.1 was overexpressed in fed-batch cultivation was as
described in Clementschitsch et al. (2005). Isolation of IBs was as
previously described by Kaar et al. (2009).
2.2. Purifying soluble sGFPmut3.1 expressed in Escherichia coli for
spiking experiments
Cell broth was centrifuged with the Contifuge Stratos Heraeus
(Thermo Fisher Scientiﬁc, Waltham, MA, USA) to gain the cell pellet.
This was suspended in a chilled (þ4 1C) solution of 10 mM Tris,
0.1 M NaCl and 0.1% Tween 20 at pH 7.5. Cell disruption was done
with the Ariete 2-stage high pressure homogenizer (GEA Niro Soavi,
Parma, Italy) at 80/800 bar in two passages. Subsequently, homo-
genate was cleared (Contifuge) and ﬁltrated with Sartopure PP2,
Sartoguard GF and Sartobran P at 1.2, 0.65 and 0.45þ0.2 mm
respectively. Buffer exchange to 10 mM Tris at pH 7.5 was done
with a Sartoﬂow advanced system with a 10 kDa Hydrosart Sarto-
coon (Satorious, Göttingen, Germany) in 7 volume changes. After,
3 chromatography steps were performed with the Äkta Pilot System
(GE Healthcare, Buckinghamshire, UK). For capturing, CaptoQ ion-
exchange resin was used. Puriﬁcation was made with Butyl-Sephar-
ose, a hydrophobic interactions chromatography. Polishing was
done by size exclusion, Superdex 75. All resins were obtained from
GE Healthcare. Quantiﬁcation of impurities were analyzed by
Superdex 75 column at the Äkta Explorer System and by SDS-PAGE,
BioRad PowerPack basic (Bio-Rad Laboratories, Hercules, USA).
2.3. Denaturing and reducing sGFPmut3.1 IBs
From IBs, sGFPmut3.1 was lyophilized, weighed and suspended
in 50 mM Tris (pH 7.3) overnight. Suspended IBs were denatured
and reduced by 1:10 ratio in dissolution buffer containing 10 M
urea, 50 mM Tris and 100 mM α-monothioglycerol (MTG) at pH
7.3 for 0.5 h. Protein concentration stock was measured on a Cary
50 Bio UV–vis Spectrophotometer (Varian, Palo Alto, USA) at a
theoretical extinction coefﬁcient of 0.813 (mg/ml protein) cm1 at
280 nm. Stock was further diluted to the desired concentrations
using buffer containing 9 M urea, 50 mM Tris, 100 mM MTG and
pH 7.3.
2.4. Determining rate constants of sGFPmut3.1 at different residual
urea
Refolding was initiated in 5 ml eppendorfs containing 0.3 M L-
arginine/HCl (SERVA, Heidelberg, Germany), 1 M Tris, 0.25 M
sucrose, 2 mM EDTA, 20 mM MTG and pH 7.3 refolding buffer in
predeﬁned urea concentrations. Solution was vortexed immedi-
ately and inserted onto laboratory rotator (SB3, Stuart) (10 rpm).
All refolding in this study took place at 2371 1C. At speciﬁed
times over 7 h, 100 ml samples were drawn and measured for
ﬂuorescence yield. Refolding concentrations of sGFPmut3.1 were
25, 38, 56, 114, 158, 190 mg/ml in residual urea concentrations of
0.24, 0.50, 0.90, 1.12, 1.32, 1.52, 1.80 M. Using Table Curve3D (SPSS,
Erkrath, Germany), kinetic constants for concentrations 25, 38,
56 mg/ml at each residual urea were calculated by ﬁtting data sets
into Eq. (4) while the higher concentrations 56, 114, 158, 190 mg/ml
were globally ﬁtted with Eq. (3) at each residual urea condition.
2.5. Batch refolding at different reducing agent concentrations
Refolding at 0.2 mg/ml sGFPmut3.1 was initiated as previously
described at 1:10 ratio dilution where 0.5 ml dissolved IBs were
added to 5 ml eppendorfs containing 4.5 ml refolding buffer
previously described but at predeﬁned MTG concentrations. The
resultant MTG concentration ranges between 10 and 100 mM.
Samples were drawn and measured for ﬂuorescence yield over
refolding time.
2.6. Establishing refolding simulation
Using fourth-order Runge–Kutta method, Eq. (1) (2) and (5)
and rate constants that were experimentally derived with increas-
ing residual urea, batch and pulse refolding simulations were
established using Microsofts Ofﬁce Excel 2013. Simulations were
veriﬁed with analytical solutions of Eqs. (3) and (4) at different
refolding conditions. Additionally, the total mass balance of inter-
mediates, native and aggregate species were always 100% over
refolding time. This simulation was then used to predict the
refolding experimental results.
2.7. Batch refolding with presence of native GFPmut3.1
Refolding was performed in 50 ml beakers at different refolding
conditions of 46, 49, 62, 95 mg/ml at a residual urea concentration
of 0.90, 0.69, 0.90, 0.90 M respectively containing speciﬁc amounts
of pure native sGFPmut3.1. As a control, identical refolding condi-
tions were also performed without pure native sGFPmut3.1. Yields
were then calculated after accounting for ﬂuorescence due to
native pure sGFPmut3.1.
2.8. SEC analysis of refolded sGFPmut3.1
Analytical SEC analysis was performed with Agilent 1290 Inﬁnity
UHPLC instrument (Agilent, Waldbronn, Germany) together with
Agilent Bio SEC-5 Column (300 mm4.6 mm i.d.) with particle size
5 mm and pore structure of 100 Å. Samples analyzed were puriﬁed
sGFPmut3.1 and refolded sGFPmut3.1 from IBs. Each analysis took
15 min where running buffer was 1 phosphate saline buffer. Flow
rate was 0.5 ml/min, column temperature was 25 1C and injection
volume was 10 ml. Absorbance was measured simultaneously at
214 nm to detect peptide bonds and 485 nm to detect ﬂuorescence
chromophore. To determine molecular weight of soluble aggre-
gates, a high molecular weight kit of 5 proteins (GE Healthcare,
Buckinghamshire, UK) between 44 and 669 kDa was analyzed.
S. Pan et al. / Chemical Engineering Science 131 (2015) 91–10092
2.9. Batch refolding of sGFPmut3.1
Refolding was performed in 50 ml beakers at different refolding
conditions at 46, 49, 51, 62, 66, 95 mg/ml at a residual urea
concentration of 0.90, 0.69, 0.47, 0.90, 0.62, 0.90 M respectively.
Refolding solution was stirred using identical magnetic bars at
500 rpm during initiation and for one minute before it was left to
stand where samples were drawn and measured for ﬂuorescence
yield over refolding time.
2.10. Pulse refolding
In four 50 ml beakers, refolding was performed in 1, 2, 3 and
4 pulses, all reaching a ﬁnal refolding protein concentration of
200 mg/ml at 0.90 M urea. Interval time between each subsequent
pulse was 90 min, protein and denaturant concentrations were
calculated in each interval for simulation prediction. Between each
pulse, samples were drawn and measured for ﬂuorescence yield.
To ensure accurate refolding conditions, pulse volumes were
corrected based on samples drawn before them.
2.11. Fluorescence measurements
Fluorescence of sGFPmut3.1 was determined by 485 nm excita-
tion and 535 nm emission with plate reader (TECAN Austria
GmbH, Salzburg, Austria) in 96 well ﬂat bottom black plate
(Thermo scientiﬁc, Denmark). Overall yield was calculated with
calibration curve from 4 to 200 mg/ml of 100 ml native sGFPmut3.1
(in-house standard).
3. Theory
Upon refolding, the formation of the molten globule inter-
mediate (I) is rapidly formed from its denatured state (U) (Arai
et al., 2002). After, intermediates undergo kinetic competition
between refolding and aggregation (Kiefhaber et al., 1991) to form
native proteins (N) and irreversible aggregates (A) (Baker and
Agard, 1994) (Fig. 1). Since this is the rate limiting step, the
conversion of intermediates can be described in a differential
equation as
dI
dt
¼ k1IK2In ð1Þ
While the formation of native proteins can be described as
dN
dt
¼ k1I ð2Þ
where k1 is the refolding rate constant, K2 is the aggregation rate
constant, n is the order of aggregation, I is the intermediate
concentration and N is the native protein concentration. The rate
constants are dependent on the refolding environment such as
temperature, redox potential and denaturant, while the aggrega-
tion order is the number of intermediates required to collide
together at enough energy for aggregation to occur.
Several proteins such as IGF-1 (Mannall et al., 2009), porcine
muscle lactic dehydrogenase (Kiefhaber et al., 1991) and 6H-
EDDIE-sGFPmut3.1 (Achmüller et al., 2007) proposed that inter-
mediates (I) undergo a competitive 1st order refolding and 2nd
order aggregation. Using Eqs. (1) and (2), the analytical solution
can be described as
Y tð Þ ¼ k1
I0k2
ln 1þ I0k2
k1
ð1ek1tÞ
 
ð3Þ
where Y is percentage conversion to native proteins, I0 [mol/l] is
the initial available intermediates, k1 [s1] is the rate constant of
folding, K2 [M/s] is the apparent rate constant of aggregation, and t
[s] the time (Kiefhaber et al., 1991) (see Appendix A for derivation).
Other proteins such as EDDIE-pep6His (Kaar et al., 2009) and
lysozyme at low concentrations (Buswell and Middelberg, 2003)
undergo a competitive 1st order refolding and 1st order aggrega-
tion (misfolding). The analytical solution can be described as
Y tð Þ ¼ k1
k1þk2
 k1
k1þk2
eðk1þk2Þt ð4Þ
where Y is the refolding yield, k1 [s1] the rate constant of folding,
k2 [s1] the rate constant of misfolding and t [s] the time (Kaar
et al., 2009) (see Appendix A for derivation).
We hypothesize there are proteins where aggregation order in
Eq. (1) changes as a function of intermediate concentration. We
deﬁne a critical intermediate concentration (Icrit), where aggrega-
tion transits from 2nd or higher to 1st order as intermediate
depletes. In this case, a single analytical solution for the entire
refolding course does not exist. For increased ﬂexibility, the
transition model is solved numerically using Eqs. (1) and (2). This
we deﬁne as
n¼ 2 when I4 Icrit
n¼ 1 when Io Icrit ð5Þ
where n is the order of aggregation, I [mol/l] the intermediate
concentration during refolding and Icrit [mol/l] the transition point
from 2nd to 1st order aggregation during refolding.
4. Results and discussion
The key objective of this work is to propose that the aggrega-
tion order of refolding proteins transits from 2nd to 1st order
aggregation as its intermediate state is depleted overtime, result-
ing in better prediction in batch and pulse refolding of proteins as
compared to conventional ﬁxed aggregation order models
(Hevehan and De Bernardez Clark, 1997; Kiefhaber et al., 1991),
using sGFPmut3.1 as our model protein.
Initially, the inﬂuence of reducing, protein and urea concentra-
tions on sGFPmut3.1 was characterized. Additionally, presence of
back aggregation of native proteins was determined. Subsequently,
simulations of proposed transition and conventional model was
established. Lastly, batch and pulse refolding experiments were
performed. Transition and conventional model prediction from
simulations was then conﬁrmed by comparing to experiments
under identical conditions.
4.1. Effect of MTG on refolding yields and kinetics of sGFPmut3.1
Since redox environment may affect refolding kinetics as
observed in lysozyme (Hevehan and De Bernardez Clark, 1997)
and α-lactalbumin (Schlegl et al., 2005), refolding was performed
at different α-monothioglycerol (MTG) concentrations between 10
and 100 mM, at 200 mg/ml sGFPmut3.1 and 0.9 M residual urea. As
shown in Fig. 2A, kinetic proﬁle and yields in all cases were very
similar, where changes in MTG have no inﬂuence on rate constants
Fig. 1. Kinetic scheme of in vitro refolding of proteins. Denatured protein (U) is
rapidly formed to intermediates (I). Intermediates are subsequently depleted
during the competitive formation between the native (N) and aggregate
(A) species.
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and refolding yields. Similarly, Inouye and Tsuji (1994) reported that
ﬂuorescence is lost upon treatment with strong reducing agents like
sodium dithionite, but not with weaker reducing agents like
2-mercaptoethanol, dithiothreitol or reduced glutathione. Structu-
rally, GFP has two cysteines at position 48 and 70, but no disulﬁde
bonds were formed. Yang et al. (1996) proposed reaction of Cys70
near one end of the cylindrical structure could disrupt the packing of
the cap on the end, allowing quenching of the chromophore. Since
MTG concentration in all refolding experiments were below the
maximal tolerable range of 10–100 mM, it should have no inﬂuence
on sGFPmut3.1 refolding kinetics.
4.2. Effect of protein refolding concentration on refolding yields
Batch refolding of sGFPmut3.1 was performed at 25, 38, 56, 114,
158, 190 mg/ml in residual urea concentrations of 0.24, 0.50, 0.90,
Fig. 2. (A) Refolding kinetics of 200 mg/ml sGFPmut3.1 and 0.9 M residual urea in reducing MTG concentrations between 10 and 100 mM. (B) Yields as a function of protein
refolding concentration. Dots represent refolding yields after 7 h refolding of sGFPmut3.1 in 1.3 M residual urea. Solid line represents model (Kiefhaber et al., 1991) describing
the competition between 1st order refolding and 2nd order aggregation of sGFPmut3.1.
Fig. 3. Refolding kinetics with and without puriﬁed native sGFPmut3.1.
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1.12, 1.32, 1.52, 1.80 M. Results were compared against conven-
tional model proposed by Kiefhaber et al. (1991) using Eq. (3) as
shown in 1.3 M residual urea (Fig. 2B). Our results showed that
conventional model is generally accurate in the concentration
dependent region above 56 mg/ml, but fail to predict yields in
the concentration independent region below 56 mg/ml. This beha-
vior was consistent for other residual urea concentrations (data
not shown). Likewise, the yields of other proteins such as lyso-
zyme (Buswell and Middelberg, 2003), the autoprotease EDDIE-
pep6His (Kaar et al., 2009) and insulin growth factors (Milner
et al., 1995) also did not reach 100% at very low concentrations.
Physically, the loss in yield suggests misfolding originating from
imperfect mixing (Mannall et al., 2006); upon addition of dena-
tured protein into refolding buffer, a gradient of moderately
denaturing conditions were formed. This populates a portion of
intermediates that favor the aggregation pathway (Brems, 1988).
Once refolding environment is homogenous, collisions between
proteins were minimized due to low refolding concentrations,
thus overall reaction was dominated between 1st order refolding
and 1st order aggregation.
In lysozyme (Buswell and Middelberg, 2003) and insulin
growth factors (Milner et al., 1995), this misfolding was presum-
ably due to incorrect disulﬁde formation (Roux et al., 1997; Saxena
and Wetlaufer, 1970). Since refolding were performed under
reducing conditions and native GFP has no disulﬁde bonds,
misfolding by incorrect disulﬁde formation was ruled out.
The exact biological reason for misfolding in GFP is unclear.
Misfolding could occur during the three sequential steps to chro-
mophore formation of GFP derived from inclusion bodies (Reid and
Flynn, 1997). Misfolding could also occur during inclusion body
formation and partially preserved even after inclusion body dissolu-
tion and reduction, since studies have shown residual secondary
structures in protein denaturation conditions by urea and GdnHCl
(Matsuo et al., 2007). Future work is needed to determine whether
GFP was formed in vivo or/and during the refolding process.
4.3. Refolding kinetics with the presence of pure native sGFPmut3.1
Buswell and Middelberg (2003) reported that the presence of
native lysozyme signiﬁcantly decreased the effective refolding yield.
This was because that native lysozyme was able to polymerize with
aggregates (Buswell and Middelberg, 2002). We checked this
possibility by adding pure native sGFPmut3.1 in our refolding buffer
before refolding.
In contrast to decrease in yields in the presence of native
lysozyme (Buswell and Middelberg, 2003), refolding yields remained
unaffected in the presence of pure native sGFPmut3.1 (Fig. 3). This
was observed evenwhen native sGFPmut3.1 concentrationwas more
than 3 times the amount of refolding concentration (Fig. 3B). If no
decrease in yields were seen, back aggregation of native sGFPmut3.1
into a non-ﬂuorescence conformation can be ruled out.
Separately, there was a higher noise level in kinetic yields
containing native sGFPmut3.1 (Fig. 3) because kinetic yields were
obtained by subtracting the total sGFPmut3.1 ﬂuorescence in
solution (pure nativeþrefolded sGFPmut3.1) with the ﬂuorescence
contributed by pure native sGFPmut3.1.
4.4. SEC analysis of refolded sGFPmut3.1
To ensure aggregates do not contain the ﬂuorescing native
sGFPmut3.1, SEC analysis was performed on both refolded
sGFPmut3.1 and pure native sGFPmut3.1. Soluble aggregates could
be seen at 214 nm (Fig. 4A), however no signal was detected at
485 nm at the same retention time (Fig. 4B). Because native
sGFPmut3.1 chromophore absorbs at 485 nm, this suggests that
soluble aggregates do not contain elements of native sGFPmut3.1.
Separately, soluble aggregates found after refolding was mea-
sured against a standard containing proteins between 44 and
669 kDa (Fig. 4A). Most of the aggregates peaked around 669 kDa
against the standard. Additionally a broad distribution of smaller
aggregates were found at lower molecular weights. Clearly, poly-
merization of aggregates was observed since aggregates were 25
folds larger than the 26.7 kDa sGFPmut3.1. Still, whether the
Fig. 4. Representative analytical SEC chromatograms of pure and refolded
sGFPmut3.1 at (A) 214 nm and (B) 485 nm absorbance.
Fig. 5. Representative refolding kinetics of sGFPmut3.1 at different refolding
concentration in 1.3 M residual urea. Solid line represent ﬁts of Eq. (3) to 25, 38
and 56 mg/ml sGFPmut3.1 refolding. Dashed lines represent global ﬁt of Eq. (4) to
concentrations 56, 114, 158 and 190 mg/ml.
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aggregation undergo sequential, multimeric (Speed et al., 1997) or
nucleation polymerization (Jarrett and Lansbury, 1992) would
require further investigation.
4.5. Simulation of batch and pulse sGFPmut3.1 refolding
Based on initial refolding experiments, evidence show that:
(1) MTG has little inﬂuence on refolding. (2) Kinetics was
concentration dependent at high concentration and independent
at a low concentration. (3) Presence of native sGFPmut3.1 do not
inﬂuence refolding yields and do not participate on sequential
polymerizationwith soluble aggregates during the refolding process.
This supports the transition model where intermediates undergo a
competing 1st order refolding and 2nd order aggregation above the
critical intermediate concentration level (Icrit), before transiting to a
competing 1st order refolding and 1st order aggregation refolding.
Fig. 6. Linear decrease in ﬁtted rate constants of sGFPmut3.1 with increasing residual urea concentrations. Both (A) and (B) were globally ﬁtted to refolding concentrations
above 56 m/ml with Eq. (4), while (C) and (D) were ﬁtted to refolding concentrations below 56 mg/ml with Eq. (3).
Fig. 7. Simulation of native, intermediate and aggregation pathways of (A) batch and (B) pulse refolding at 4 pulses of 90 min intervals to a ﬁnal concentration of 200 mg/ml
sGFPmut3.1 and 0.9 M residual urea.
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Although it is difﬁcult to determine the exact value of Icrit and
also if a gradient from 2nd to 1st order aggregation exists, based
on refolding experiments at different protein and residual urea
concentrations as shown in Fig. 2B and Fig. 5, we assumed a step
transition at an estimated Icrit value of 56 mg/ml. To determine the
effect of residual urea on rate constants, kinetics of different
protein concentrations of the same residual urea above 56 mg/ml
were globally ﬁtted to Eq. (3), while different protein concentra-
tion below 56 mg/ml of their respective residual urea were ﬁtted
with Eq. (4) as shown in Fig. 5. In all cases, ﬁtted rate constants
showed a linear relationship for both refolding and aggregation
constants (Fig. 6).
To test if the transition model is mechanistically accurate, we
ﬁrst establish a simulation using ﬁtted rate constants and pro-
posed model, calculating the conversion of intermediates to
refolded and aggregated species in batch and pulse refolding
(Fig. 7). As expected with previous empirical studies (Winter
et al., 2002), pulse refolding attained greater yield than batch
refolding under same refolding conditions. This simulation was
later used to predict the kinetics and veriﬁed with refolding
experiments.
4.6. Batch refolding and simulation prediction
To better observe transition effects from 2nd to 1st order
aggregation as intermediates deplete, batch refolding experiments
were performed above and below Icrit, between 49 and 95 mg/ml
(Fig. 8). In all cases, proposed model predicted more accurately
than a pure 2nd order simulation applied in previous studies (Kaar
et al., 2009; Kiefhaber et al., 1991; Mannall et al., 2009; Schlegl
et al., 2003). The pure 2nd order model over estimated refolding
kinetics because it assumes that in low intermediate concentra-
tions, yields would become higher as aggregation is suppressed. In
contrast, proposed model accounts for the effects of 1st order
aggregation (misfolding) once intermediates were depleted to
lower concentrations at later stages of refolding.
4.7. Pulse refolding and simulation prediction
To ensure that transition model can be applied to other reactor
formats (Buswell and Middelberg, 2003; Ding et al., 2010), pulse
refolding was performed experimentally from 1 pulse (batch) to
4 pulses, reaching a ﬁnal protein and residual urea concentration of
200 mg/ml and 0.9 M respectively. Consistent with pulse refolding on
human proinsulin (Winter et al., 2002) and the autoprotease 6His-
EDDIE-sGFPmut3.1 (Pan et al., 2014), experimental results showed
yield improvements from batch to pulse refolding (Fig. 9).
Overall, pulse refolding for both models over predicted results.
However over prediction was greater in the pure 2nd order model
of up to 12% than transition model of up to 5% (Fig. 9). Additionally,
over estimation increased with increasing number of pulses
(Fig. 9B–D). From this over estimation, we question if the pure
native sGFPmut3.1 artiﬁcially added into refolding buffer was truly
representative to sGFPmut3.1 that was just refolded, since the
presence of pure native sGFPmut3.1 did not affect the yields and
kinetics of refolding sGFPmut3.1 (Fig. 3). In contrast, yields were
Fig. 8. Predicted simulations and experimental results of batch refolding. Dotted lines represent 1st order refolding and 2nd order aggregation model simulation. Solid lines
represent transition model.
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lower when denatured sGFPmut3.1 were added to solution con-
taining sGFPmut3.1 that was just refolded, as was the case in pulse
refolding.
Considering there was over prediction in the transition model,
it was possible that freshly refolded sGFPmut3.1 was still not as
stable as the pure native form, resulting in a small proportion of
the freshly refolded sGFPmut3.1 reverting to a non-ﬂuorescence
conformation. With increasing number of pulses, this unstable
proportion got bigger, as a higher protein concentration should
result in greater instability, and thus lower ﬂuorescence yields.
Separately for batch refolding of 1 pulse (Fig. 9A), the pure 2nd
order model gave a better prediction than transition model. How-
ever this prediction was reactor speciﬁc (Ding et al., 2010) because
using alternative refolding strategies like pulse refolding for Fig. 9B–
D showed weaker prediction for the pure 2nd order model.
Speciﬁcally, because protein refolding in batch refolding was
200 mg/ml, the inﬂuence of depleted intermediates in the 1st order
aggregation region (Io56 mg/ml) were smaller compared when
intermediates were in the 2nd order aggregation region (56 mg/
mlo Io200 mg/ml), therefore the pure 2nd order model was
sufﬁcient to predict the kinetic pathway.
Overall, as summarized in Table 1, the mean squared error for
the transition model is mostly lower than the 2nd order aggrega-
tion model, suggesting that the accuracy of prediction by the
former was better. However the transition model showed that
mean squared values increased with increasing number of pulses.
This could be due to freshly refolded sGFPmut3.1 reverting to a
non-ﬂuorescence conformation as previously explained. Still,
further studies would still be required to conﬁrm this explanation.
5. Further discussion
Theoretically, a higher order of aggregation would mean a higher
refolding yield (when all other factors are kept equal). This is
rational because with increasing aggregation order, more intermedi-
ates are required to collide together at enough energy for aggrega-
tion formation to occur. Since aggregation becomes less frequent,
more intermediates follow the competing refolding pathway thus
higher refolding yield is observed.
Fig. 9. Predicted simulations and experimental results of pulse refolding. Dotted lines represent 1st order refolding and 2nd order aggregation model simulation. Solid lines
represent transition model.
Table 1
Accuracy of predictions calculated using mean squared error (MSE) between the
respective simulation and experimental results.
Pulses Urea
concentration
(M)
Protein
concentration
(mg/ml)
2nd Order
aggregation model
(MSE)
Transition
aggregation
model (MSE)
1 0.90 95 8.26104 5.04104
1 0.62 66 2.11103 7.59104
1 0.90 62 3.02103 5.14104
1 0.69 49 5.63103 8.26104
1 0.90 200 1.36104 6.17104
2 0.90 200 1.44103 4.14104
3 0.90 200 3.45103 1.21103
4 0.90 200 4.40103 1.26103
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In reality, intermediates to aggregate formation is complex
because multiple aggregation orders could occur simultaneously
over time. At high intermediate concentrations, aggregate forma-
tion could occur from a distribution of many different intermedi-
ates colliding together. As intermediate depletes, higher orders
become less probable as collisions decreased, while 1st order
aggregation dominates. Ideally, if all aggregation orders can be
quantitatively determined, a precise model could be described by a
model that includes all participating aggregation orders.
However, we were limited by analytical methods where inter-
mediates to aggregate formation could not be quantitatively
measured. Conventional measurements by light scattering could
only give a qualitative behavior of overall polymerization aggrega-
tion mechanism (Buswell and Middelberg, 2002; Speed et al.,
1997) and is unable to speciﬁcally measure the initial formation
from intermediate to aggregate species.
Nevertheless, since the refolding kinetics by sGFPmut3.1 could be
determined by ﬂuorescence, aggregation kinetics could still be
determined, because any intermediate that was not converted to
native form was converted to the aggregate form. From this, we
showed that a transition from 2nd to 1st order aggregation as
intermediate depletes can better predict both batch and pulse
refolding than a ﬁxed order aggregation. Importantly, this showed
that a transition, apparently dominated by 2nd to 1st order aggrega-
tion order, exists during refolding which was non-reactor speciﬁc.
However further rigorous study is still required, particularly in
determining the transition type (step or gradient) from a higher to
lower order aggregation, the precise aggregation mechanism and the
stability of refolded sGFPmut3.1 to improve accuracy of the model.
The transition model could be applied to other proteins,
particularly if refolding yields did not reach high yields at low
refolding concentrations, which deviates from the conventional ﬁx
ordered aggregation model. Clearly, refolding is highly dependent
on protein structure and refolding conditions. Replicating this
experiment on another protein with a different structure would
be important to verify if developed model can be used to predict
the refolding yield of other proteins. However the stability,
analytical, back aggregation or redox issues using other proteins
would not quickly allow clear elucidation in the transition model
and is beyond the scope of current study.
In contrast, we used GFP as a model protein for its stability, fast
and accurate analysis by ﬂuorescence, no polymerization with
aggregates and no inﬂuence of redox on refolding kinetics. Its
refolding characteristic makes it ideal to perform batch and pulse
experiments, elucidating the transition from 2nd order aggrega-
tion to 1st order misfolding as intermediates deplete. This transi-
tion behavior should not be speciﬁc to GFP, although GFP allows
technical and conceptual advantages, providing a clear distinction
of the phenomena that is otherwise difﬁcult to observe in other
proteins.
Although experiments on other proteins was not performed, the
refolding equilibrium of lysozyme (Buswell and Middelberg, 2003)
and insulin growth factors (Milner et al., 1995) from previous work
at low concentrations also did not reach 100%, deviating from the
ﬁxed ordered aggregation model. This suggests that misfolding also
occurs in other proteins at low concentrations, in agreement with
the transition model. Therefore, applying the ﬁxed-order aggrega-
tion, ﬁrst-order refolding theoretical model would overestimate
refolding yields at low protein concentrations. This has implications
due to the emphasis on low-protein-concentration refolding stra-
tegies in biomanufacturing.
Although the biological reasons may differ in the aggregation and
misfolding between different proteins, the mathematical description
in the transition of aggregation order during the refolding process
should still be similar. Including this behavior on proteins that
exhibit an aggregation transition order should lead to more accurate
refolding models; the extent of this improvement will depend on
the speciﬁc protein and its refolding conditions.
6. Conclusion
Overall, the transition model gave better prediction of batch
and pulse refolding strategies than conventional model. This
describes the competition of sGFPmut3.1 intermediates between
1st order refolding and 2nd order aggregation above a critical
intermediate concentration (Icrit) before aggregation becomes 1st
order when depleted below Icrit. This simple but realistic model
may serve as an engineering tool to optimize in vitro protein
refolding in bioprocess settings.
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Appendix A
A.1. Solving conventional 1st order refolding with 2nd order
aggregation differential equation
From Eq. (1) in manuscript, for 2nd order aggregation, n¼2
dI
dt
¼ k1IK2I2 ðA:1Þ
Rearrange Eq. (A.1) to solve differential equation, where t¼0,
I¼ I0Z I
I0
1
k1IK2I2
dI ¼
Z t
0
1 dt ðA:2Þ
Solving Eq. (A.2) by integration leads to
IðtÞ ¼ I0k1
K2I0 ek1t1
 þk1ek1t ðA:3Þ
Eq. (A.3) describes intermediates (I) depleting over time during
refolding.
Rearrange Eq. (A.3) to facilitate integration in later steps
IðtÞ ¼ I0e
k1t
1þ I0K2=k1
 ð1ek1tÞ ðA:4Þ
Substitute Eq. (A.4) into Eq. (2) in manuscript
dN
dt
¼ ðk1Þ
I0ek1t
1þ I0K2=k1
 ð1ek1tÞ ðA:5Þ
Rearrange Eq. (A.5) to solve differential equation, where t¼0,
N¼0
Z N
0
1 dN ¼ k1
Z t
0
I0ek1t
1þ I0K2=k1
 ð1ek1tÞ dt ðA:6Þ
Solving Eq. (A.6) by integration leads to
N tð Þ ¼ k1
k2
ln 1þ I0k2
k1
ð1ek1tÞ
 
ðA:7Þ
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Eq. (A.7) describes native (N) forming over time during
refolding.
Therefore, percentage of intermediates converted to native
proteins (Y) over time is given by
Y tð Þ ¼ k1
I0k2
ln 1þ I0k2
k1
ð1ek1tÞ
 
ðA:8Þ
A.2. Solving conventional 1st order refolding with 1st order
aggregation differential equation
From Eq. (1) in manuscript, for 1st order aggregation, n¼1
dI
dt
¼ k1IK2I1 ðA:9Þ
Rearrange Eq. (A.9) to solve differential equation, where t¼0,
I¼ I0Z I
I0
1
k1IK2I1
dI¼
Z t
0
1 dt ðA:10Þ
Solving Eq. (A.10) by integration leads to
IðtÞ ¼ I0 e tðk1þk2Þ ðA:11Þ
Eq. (A.11) describes intermediates (I) depleting over time
during refolding.
Substitute Eq. (A.11) into Eq. (2) in manuscript
dN
dt
¼ ðk1ÞI0e tðk1 þk2Þ ðA:12Þ
Rearrange Eq. (A.12) to solve differential equation, where t¼0,
N¼0
Z N
0
1 dN ¼ k1
Z t
0
I0e tðk1þk2Þ dt ðA:13Þ
Solving Eq. (A.13) by integration leads to
N tð Þ ¼ I0
k1
k1þk2
 k1
k1þk2
eðk1þk2Þt
 
ðA:14Þ
Eq. (A.14) describes native (N) forming over time during
refolding.
Therefore percentage of intermediates converted to native
proteins (Y) over time is given by
Y tð Þ ¼ k1
k1þk2
 k1
k1þk2
eðk1þk2Þt ðA:15Þ
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